Search

Search Constraints

You searched for: Author/Creator Fontana, M

Search Results

1. 015 Clinical utility of T1 mapping in cardiac ATTR amyloidosis – diagnostic performance and prognostic capability. (3rd April 2017)

4. 29 Synthetic ECV – simplifying ECV quantification by deriving haematocrit from T1 blood. (26th April 2015)

6. A multi-modality, multi-parametric phenotyping study of transthyretin amyloid cardiomyopathy associated with the p.V142I TTR variant. (3rd October 2022)

7. AB1064 Carpal tunnel biopsy and bone scintigraphy using the technetium-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99M) (TC-DPD) tracer can identify clinically silent cardiac amyloidosis at a potentially treatable stage. (15th June 2017)

9. AS-amyloidosis. Dual pathology or novel disease? A multimodality, multi-centre assessment across health and disease. (8th February 2021)

10. Atrial strain in cardiacATTR amyloidosis from pathophysiology to prognosis: is it time to rethink our approach to disease?. (25th November 2020)